NEW YORK (GenomeWeb) – GenomeDx Biosciences announced today that Medicare administrative contractor Noridian GBA has issued a draft local coverage determination for use of the firm's Decipher Prostate Biopsy genomic classifier in patients with very low and low-risk prostate cancer as defined by National Comprehensive Cancer Network guidelines.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.